{"result": "(\"entity\"<|>EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER<|>ORGANIZATION<|>The European Association for the Study of the Liver is a professional organization focused on liver diseases and their management, known for publishing clinical practice guidelines.)\n##\n(\"entity\"<|>WILSON'S DISEASE<|>EVENT<|>Wilson's disease is a genetic disorder that leads to excessive copper accumulation in the body, causing various health issues, particularly affecting the liver and brain.)\n##\n(\"entity\"<|>KALER SG<|>PERSON<|>Kaler SG is a researcher known for contributions to the understanding of ATP7A-related copper transport diseases, including Wilson's disease.)\n##\n(\"entity\"<|>HARVEY LJ<|>PERSON<|>Harvey LJ is a researcher who has studied copper metabolism and its implications in human health.)\n##\n(\"entity\"<|>FERENCI P<|>PERSON<|>Ferenci P is a researcher involved in the study of Wilson's disease and its diagnostic criteria.)\n##\n(\"entity\"<|>TRUMBO P<|>PERSON<|>Trumbo P is a researcher who has contributed to dietary reference intakes, including those relevant to copper and other trace elements.)\n##\n(\"relationship\"<|>EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER<|>WILSON'S DISEASE<|>The European Association for the Study of the Liver publishes clinical practice guidelines related to Wilson's disease<|>8)\n##\n(\"relationship\"<|>KALER SG<|>WILSON'S DISEASE<|>Kaler SG has conducted significant research on the molecular mechanisms of Wilson's disease<|>7)\n##\n(\"relationship\"<|>HARVEY LJ<|>WILSON'S DISEASE<|>Harvey LJ has researched copper metabolism, which is crucial for understanding Wilson's disease<|>6)\n##\n(\"relationship\"<|>FERENCI P<|>WILSON'S DISEASE<|>Ferenci P has worked on the diagnosis and treatment guidelines for Wilson's disease<|>7)\n##\n(\"relationship\"<|>TRUMBO P<|>WILSON'S DISEASE<|>Trumbo P's research on dietary reference intakes includes elements relevant to the management of Wilson's disease<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: -                       collagen and elastin. Med Biol.1982;60(2):45-8.\nmiento inicial sintomático, ya que su inicio de acción es            3. Schilsky ML, Oikonomou I. Inherited metabolic liver\nlento. Aunque se considera un agente de tercera línea,                  disease. Curr Opin Gastroenterol. 2005;21(3):275-82.\n---\n 434      BLOQUE: METABOLISMO\n\n\n\n  4.  Mesa Latorrea JM, García Díaza JD, Corps Fernández    18.  Rodríguez-Castro KI, Hevia-Urrutia FJ, Sturniolo\n      D, Valbuena Parra AR. Trastornos del metabolismo           GC. Wilson’s disease: A review of what we have\n      del hierro y del cobre. Hemocromatosis y enferme-          learned. World J Hepatol. 2015; 7(29):2859-70.\n      dad de Wilson Medicine. 2016;12(19):1094-106.         19.  Roberts EA and Schilsky ML. Diagnosis and treat-\n  5.  Brewer GJ. Neurologically presenting Wilson’s dis-         ment of Wilson Disease: an update. AASLD Practice\n      ease: epidemiology, pathophysiology and treat-             Guidelines. Hepatology 2008;47(6):2089-111.\n      ment. Drugs. 2005;19(3):185-92.                       20.  Bandmann O, Weiss KH, Kaler SG. Wilson’s dis-\n  6.  Harvey LJ, Dainty JR, Hollands WJ, Bull VJ, Beattie        ease and other neurological copper disorders. Lan-\n      JH, Venelinov TI, et al. Use of mathematical mod-          cet Neurol 2015;14:103–13.\n      eling to study copper metabolism in humans. Am        21.  Bruha R, Marecek Z, Pospisilova L, et al. Long-term\n      J Clin Nutr. 2005;81(4):807-13.                            follow-up of Wilson disease: natural history, treat-\n  7.  van den Berghe PV, Klomp LW. New developments              ment, mutations analysis and phenotypic correla-\n      in the regulation of intestinal copper absorption.         tion. Liver Int 2011; 31: 83–91.\n      Nutr Rev. 2009;67(11):658-72.                         22.  Walshe JM. Cause of death in Wilson disease. Mov\n  8.  Kaler SG. ATP7A-related copper transport diseas-           Disord 2007;22:2216–20.\n      es-emerging concepts and future trends. Nat Rev       23.  Fritzsch D, Reiss-Zimmermann M, Trampel R, Turn-\n      Neurol. 2011;7(1):15-29.                                   er R, Hoff mann KT, Schäfer A. Seven-tesla mag-\n  9.  Wu F, Wang J, Pu C, Qiao L, Jiang C. Wilson’s dis-         netic resonance imaging in Wilson disease using\n      ease: a comprehensive review of the molecular              quantitative susceptibility mapping for measure-\n      mechanisms. Int J Mol Sci. 2015;16(3):6419-31.             ment of copper accumulation. Invest Radiol 2014;\n10.   European Association for the Study of the Liver.           49: 299–306.\n      EASL Clinical Practice Guidelines: Wilson’s disease.  24.  Ferenci P, Steindl-Munda P, Vogel W, et al. Diag-\n      Journal of Hepatology 2012;56:671–85.                      nostic value of quantitative hepatic copper deter-\n11.   Trumbo P, Yates AA, Schlicker S, Poos M. Dietary           mination in patients with Wilson’s Disease. Clin\n      reference intakes: vitamin A, vitamin K, arsenic,          Gastroenterol Hepatol 2005; 3: 811–18.\n      boron, chromium, copper, iodine, iron, manga-         25.  Cauza E, Maier-Dobersberger T, Ferenci P. Plasma\n      nese, molybdenum, nickel, silicon, vanadium, and           ceruloplasmin as screening test for Wilson’s dis-\n      zinc. J Am Diet Assoc. 2001;101(3):294-301.                ease. J Hepatol 1997;27:358–62.\n12.   García Luna PP y Pereira Cunill JL. Dieta controlada  26.  Kelly   D,  Crotty    G,   O’Mullane      J,  Stapleton     M,\n      en cobre. Salas Salvadó J, Bonada A, Trallero R y          Sweeney B, O’Sullivan SS. The Clinical Utility of a\n      Saló ME eds. Nutrición y dietética clínica. Barcelo-       Low Serum Ceruloplasmin Measurement in the\n      na. Editorial Doyma SL. 2000:389-91.                       Diagnosis of Wilson Disease. Ir Med J. 2016;109:\n13.   Mataix Verdú J, Mañas Almendros M eds.\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}